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Abstract: Increased life expectancy has promoted research on healthy aging. Aging is accompanied
by increased non-specific immune activation (inflammaging) which favors the appearance of several
disorders. Here, we study whether dietary supplementation with spray-dried animal plasma (SDP),
which has been shown to reduce the activation of gut-associated lymphoid tissue (GALT) in
rodents challenged by S. aureus enterotoxin B (SEB), and can also prevent the effects of aging
on immune system homeostasis. We first characterized GALT in a mouse model of accelerated
senescence (SAMP8) at different ages (compared to mice resistant to accelerated senescence; SAMR1).
Second, we analyzed the SDP effects on GALT response to an SEB challenge in SAMP8 mice. In GALT
characterization, aging increased the cell number and the percentage of activated Th lymphocytes in
mesenteric lymph nodes and Peyer’s patches (all, p < 0.05), as well as the expression of IL-6 and TNF-α
in intestinal mucosa (both, p < 0.05). With respect to GALT response to the SEB challenge, young
mice showed increased expression of intestinal IL-6 and TNF-α, as well as lymphocyte recruitment
and activation (all, p < 0.05). However, the immune response of senescent mice to the SEB challenge
was weak, since SEB did not change cell recruitment or the percentage of activated Th lymphocytes.
Mice supplemented with SDP showed improved capacity to respond to the SEB challenge, similar to
the response of the young mice. These results indicate that senescent mice have an impaired mucosal
immune response characterized by unspecific GALT activation and a weak specific immune response.
SDP supplementation reduces non-specific basal immune activation, allowing for the generation of
specific responses.
Keywords: intestinal inflammation; S. aureus enterotoxin B; aging; spray-dried animal plasma;
functional proteins
1. Introduction
Aging is an intrinsic process that impairs the function of cells, tissue, organs, and individuals. It is
characterized by an increased inflammatory state and physiological changes that involve a reduction
in the response to environmental stimuli. These, in turn, increase predisposition to illness and death.
Francheschi et al. [1] introduced the concept of inflammaging, to define chronic low-grade
inflammation that is shared by a broad spectrum of age-related pathologies. Inflammaging is caused
by cumulative exposure to antigen loads, triggered by both clinical and subclinical infections, as well as
exposure to non-infective antigens [2]. The resulting inflammatory condition involves the increased
production of reactive oxygen species and pro-inflammatory cytokines, affecting both the innate [3] and
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acquired [4] immune system. This results in a vicious circle, which drives immune system remodeling
and eventually favors a chronic pro-inflammatory state [5]. Hence, high plasma IL-6, IL-1, TNF-α,
and C-reactive protein concentrations are associated with a higher risk of morbidity and mortality in
elderly people [5].
The inflammaging profile is paralleled by changes in the immune system associated with aging
that are known as immunosenescence. This is characterized by a decline in immune competence
associated with a reduction in the secretion of specific IgA into the intestinal lumen, and a reduced
capacity to generate tolerance to antigens [6]. This means that, in aged individuals, the protective
function of gut-associated lymphoid tissue (GALT) is compromised.
In addition to progressive age-related GALT deterioration, the intestine is permanently exposed
to food and environmental antigens, which are responsible for the permanent low-grade inflammation
that characterizes the gut mucosa [7]. This condition can be reproduced in the laboratory by systemic
administration of Staphylococcus aureus enterotoxin B (SEB), because it induces polyclonal activation
of T cells, especially in the small intestine [8]. This results in mild stimulation of the secretion of
pro-inflammatory cytokines [9–11].
Dietary intervention can modulate GALT activation. Dietary supplementation with functional
proteins from porcine plasma (spray-dried plasma; SDP) has been shown to prevent the deterioration
of the intestinal barrier and defense mechanisms, thereby reducing the degree of GALT activation
in animals challenged by SEB [12,13]. The mechanism of action of SDP involves a reduction in
the number of activated Th lymphocytes and stimulation of the Treg population, which restores
the pro-/anti-inflammatory cytokine profile. This pattern has been extensively observed in the small
intestine of rats [10] and mice [11].
Our aim here was to analyze whether SDP supplementation is effective in preventing
the low-grade inflammation associated with senescence, and therefore whether supplemented animals
are able to respond to an SEB challenge.
2. Materials and Methods
2.1. Animals and Diets
Male mice of the SAMP8 strain (prone to accelerated senescence) and its control senescence-resistant
counterpart (SAMR1) [14] were obtained from Envigo (Bresso, Italy). The colonies generated were kept
at the animal facility of the Faculty of Pharmacy and Food Science of the University of Barcelona under
stable temperature and humidity conditions, with a 12 h:12 h light/dark cycle. All the protocols used in
this study were approved by the Ethics Committee for Animal Use of the University of Barcelona and
the Generalitat de Catalunya regional authorities (registration numbers 565/13 and 7397, respectively).
2.2. Experimental Design
Experiment 1. Characterization of GALT of SAMR1 and SAMP8 mice. In this experiment we used
SAMP8 and SAMR1 mice at 2, 6, and 9 months of age. In these animals, the leukocyte populations in
mesenteric lymph nodes (MLN) and Peyer’s patches (PP) were determined, as well as the expression
of the pro-inflammatory cytokines Il-6 and Tnf-α in the jejunum mucosa.
Experiment 2. Acute intestinal inflammation. In this experiment we used SAMP8 mice
at 2 months of age (as young animals; 2M group), at 6 months of age (as reference senescent
mice; 6M group), and at 6 months of age having been fed an SDP diet (as SDP senescent mice;
6M-SDP group). The mice received the experimental diets (Control diet and SDP diet; Table 1)
from 2 to 6 months of age. Body weight evolution was recorded monthly and food consumption was
recorded two times per week. Before SEB administration, blood was obtained by cheek puncture to
measured plasma cytokines (IL-6, TNF-α). Intestinal inflammation was induced by an intraperitoneal
administration of 25 µg SEB, while non-challenged mice received only the vehicle (phosphate buffered
saline; PBS). All animals were killed by anesthetic overdose, 24 h after SEB or vehicle administration.
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In these animals were determined the leukocyte populations in MLN and PP, as well as the expression of
the pro-inflammatory cytokines IL-6 and TNF-α in the jejunum mucosa.
Table 1. Composition of experimental diets.
Ingredients
Control Diet SDP 1 Diet
g/kg
SDP - 80.0
Dried skim milk 530.7 340.5
Corn starch 199.3 308.8
Sucrose 94.5 94.5
Soybean oil 70 70
Cellulose 50 50
AIN-93-G-MX (94046) 2 35 35
AIN-93 VX (94047) 2 15 15
DL-Methionine 2.5 3.2
Choline bitartrate 3 3
1 SDP (spray-dried plasma) was provided by APC Europe, S.L.U., Granollers, Spain; 2 AIN-93 VX, vitamin mix;
AIN-93-G-MX, mineral mix. Both were provided by Envigo, Bresso, Italy.
2.3. MLN Cell Isolation
Leukocytes from MLN were obtained as previously described [11]. Briefly, MLN were finely minced
and incubated in a digestion solution composed of RPMI-1640 (Invitrogen, Carlsbad, CA, USA) with 5%
inactivated fetal bovine serum (FBS), 100,000 U/L penicillin, 100 mg/L streptomycin, 10 mM HEPES,
2 nM L-glutamine, and 150 U/mL collagenase (Invitrogen, Carlsbad, CA, USA) at 37 ◦C in a shaker
(Thermomixer Comfort Eppendorf®, Heuppauge, NY, USA). MLN were mechanically disaggregated
and passed through a stainless-steel mesh. The cell suspension was centrifuged at 500× g for 10 min
at 4 ◦C. The pelleted cells were resuspended in PBS-FBS. Cell number and viability were determined
using acridine orange and ethidium bromide markers.
2.4. PP Cell Isolation
Leukocytes from PP were obtained as previously described [9]. The PP were excised and incubated
in the solution previously described for MLN. The PP were then mechanically disaggregated and
passed through a stainless-steel mesh. The resulting cell suspensions were centrifuged at 500× g for
10 min at 4 ◦C. The pelleted cells were resuspended in 40% Percoll™ (GE Healthcare Bio-Sciences,
Little Chalfont, Bucks, UK) in complete RPMI. This cell suspension was carefully layered over 80%
Percoll™ in complete RPMI medium and centrifuged at 700× g for 20 min at 20 ◦C. The ring of cells
was carefully collected, transferred to a clean tube, and centrifuged at 500× g for 10 min at 4 ◦C.
The pelleted cells were resuspended in PBS-FBS. Cell number and viability were determined using
acridine orange and ethidium bromide markers.
2.5. Cell Staining
A total of 3× 105 cells were stained, as described previously by Pérez-Bosque et al. [9]. The conjugated
primary antibodies used were anti-CD4 (GK1.5), anti-CD25 (PC61.5), and FoxP3 (FJK-16S), all obtained
from eBioscience (San Diego, CA, USA). The stained cells were measured in a Gallios Flow cytometer
(Beckman Coulter, Miami, FL, USA), located at the Cytometry Unit of the Scientific-Technical Services
of the Barcelona Science Park. The results were analyzed using the Flowjo® software (version 7.6.5,
Treestar Inc., Ashland, OR, USA). Lymphocytes and non-lymphocytic leucocytes were separated by
forward/side scatter.
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2.6. Serum Cytokine Determination
Serum concentration IL-6 and TNF-α were measured by Bio-Plex Cytokine Assay™ (Bio-Rad,
Hercules, CA, USA).
2.7. Real-Time Polimerase Chain Reaction
RNA extraction, reverse transcription, and real-time polymerase chain reaction (PCR) were
carried out as described previously by Pérez-Bosque et al. [11]. The primers used are shown in
Table 2. The target gene transcripts were quantified using Glucuronidase β (Gusβ) gene expression as
a reference, using the 2−∆∆CT method [15]. Product fidelity was confirmed by melt-curve analysis.
Table 2. Primers used for real-time PCR.
Primer Forward (5′-3′) Reverse (5′-3′) Fragment Size Accession Number
Gusβ CCGATTATCCAGAGCGAGTATG CTCAGCGGTGACTGGTTCG 197 bp NM_010368.1
Il-6 ACCAGAGGAAATTTTCAATAGGC TGATGCACTTGCAGAAAACA 109 bp NM_031168.1
Il-10 GGCGCTGTCATCGATTTCTCCCC TGGCCTTGTAGACACCTTGGTCTT 102 bp NM_010548.2
Inf-γ CCTTCTTCAGCAACAGCAAGGCG CTTGGCGCTGGACCTGTGGG 87 bp NM_008337.4
Tnf-α CCACCACGCTCTTCTGTCTAC AGGGTCTGGGCCATAGAACT 103 bp NM_013693.2
Gusβ, glucuronidase β; Il-6, Interleukin 6; Il-10; interleukin 10; Inf-γ, interferon-γ; Tnf-α, tumoral necrosis factor α.
2.8. Statistical Analysis
The results of the experiments are presented as the means ± standard error of the mean (SEM).
The data were analyzed by two-way ANOVA followed by the Fisher’s least significant difference (LSD)
post-hoc test, using GraphPad Prism® software (version 6, GraphPad Software, Inc., La Jolla, CA,
USA). In the first experiment, the factors considered were the strain of mice and age. In the second
experiment, in body weight evolution and food consumption data the factors were time and diet;
while in the immune variables the factors were age and dietary supplementation (considered together
as a group variable: 2M, 6M, 6M-SDP), and SEB-induced inflammation. Plasma cytokines data was
analyzed by one-way ANOVA followed by the Fisher’s LSD post-hoc test. Differences were considered
significant at p < 0.05.
3. Results
3.1. Characterization of GALT in SAM Strains
3.1.1. MLN Populations in SAM Strains
SAMP8 mice showed lower MLN leukocyte counts than the SAMR1 strain at all of the ages
studied (p = 0.001, Figure 1A). The percentage of activated Th lymphocytes in SAMP8 MLN was higher
than that in SAMR1 (p < 0.001, Figure 1B), and this effect was enhanced in the older mice (interaction;
p < 0.001). In contrast, SAMR1 mice showed higher percentages of regulatory Th lymphocytes
than SAMP8 mice (p = 0.043, Figure 1C). Moreover, the percentage of this population increased with
age (p = 0.003). The ratio of activated to regulatory Th lymphocytes in MLN was significantly higher
in SAMP8 than in SAMR1 mice (p < 0.001, Figure 1D) and this effect was more evident at 9 months of
age, indicating a significant interaction between mouse strain and age (p = 0.005).
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Figure 1. Cell recruitment (A); percentage of activated (Act.) Th lymphocytes (B); percentage of
regulatory (Treg) Th lymphocytes (C); and the ratio of activated to regulatory Th lymphocytes (D),
in mesenteric lymph nodes (MLN) of SAMR1 and SAMP8 mice at 2, 6, and 9 months of age. The open
bars represent SAMR1 mice; the solid bars, SAMP8 mice. Results are expressed as means ± SEM
(n = 5–11 animals). Means without a common letter differ, p < 0.05. Int., interaction between factors
(age and mice strain).
3.1.2. PP Populations in SAM Strains
As for MLN, the PP cell count was higher in SAMR1 mice than in SAMP8 mice (p = 0.003,
Figure 2A), and increased with age in both mice strains (p = 0.047). The percentage of activated
Th lymphocytes was higher in SAMP8 mice than in SAMR1 mice (p < 0.001, Figure 2B) and also
increased with age (p < 0.001). Moreover, the effect of age was more pronounced in SAMP8 mice
than in SAMR1 mice (p = 0.001). The percentage of regulatory Th lymphocytes decreased in mice
from both strains at 9 months of age (p < 0.001; Figure 2C). The ratio of activated to regulatory
Th lymphocytes increased with age (p < 0.001, Figure 2D).
Figure 2. Cont.
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Figure 2. Cell recruitment (A); percentage of activated (Act.) Th lymphocytes (B); percentage of regulatory
(Treg) Th lymphocytes (C); and the ratio of activated to regulatory Th lymphocytes (D), in Peyer’s
patches (PP) of SAMR1 and SAMP8 mice at 2, 6, and 9 months of age. The open bars represent SAMR1 mice;
the solid bars, SAMP8 mice. Results are expressed as means ± SEM (n = 5–10 animals). Means without
a common letter differ, p < 0.05. Int., interaction between factors (age and mice strain).
3.1.3. Pro-Inflammatory Cytokines in SAM Strains
SAMP8 mice showed higher expression levels of Il-6 and Tnf-α in their jejunum mucosa than SAMR1
mice (p = 0.003 and p < 0.001, respectively, Figure 3A,B). Aging increased the intestinal expression of both
cytokines in both mice strains (p = 0.001 and p < 0.001, respectively), although SAMP8 mice exhibited
a more evident effect of age on expression of Tnf-α than SAMR1 mice (p = 0.007).
Figure 3. mRNA expression of Il-6 (A) and Tnf-α (B), in the jejunum mucosa of SAMR1 and SAMP8
mice at 2, 6, and 9 months of age. The open bars represent SAMR1 mice; the solid bars, SAMP8 mice.
All the target genes were normalized to glucuronidase β (Gusβ) expression. The fold change expression
is related to SAMR1 mice of 2 months of age. Results are expressed as means ± SEM (n = 6–7 animals).
Means without a common letter differ, p < 0.05. Int., interaction between factors (age and mice strain).
3.2. Effect of SDP on Senescent Mice
3.2.1. Effect of SDP on Systemic Variables
SDP supplementation did not modify body weight evolution nor food consumption (Figure S1).
The concentration of pro-inflammatory cytokines IL-6 and TNF-α increased in the serum of senescent
mice (p < 0.001 and p = 0.011; Figure 4), and SDP supplementation reduced both cytokines in aged
mice (p = 0.046 and p = 0.041, respectively).
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Figure 4. Serum concentration of IL-6 (A) and TNF-α (B) of SAMP8 mice of the 2-month-old (2M),
6-month-old (6M), and 6-month-old fed spray-dried plasma (6M-SDP) groups. Results are expressed
as means ± SEM (n = 6–7 animals). Means without a common letter differ, p < 0.05.
3.2.2. Effect of SDP on MLN Populations in Senescent Mice
As stated for the previous result, senescent mice (6 months old) showed increased cell recruitment
into MLN under basal conditions (p < 0.001), which was attenuated by SDP supplementation (p = 0.043).
SEB administration increased cell recruitment into MLN (p = 0.031, Figure 5A), although senescent mice
fed the control diet showed a weaker response to SEB administration than young mice or senescent
mice supplemented with SDP (p = 0.019). SEB administration increased the percentage of activated
Th lymphocytes (p < 0.001; Figure 5B). SEB had no effect on aged mice (6M) fed the control diet, while
young SAMP8 and SDP-supplemented old mice responded to administration of the toxin (p < 0.001).
Neither senescence nor dietary supplementation with SDP modified the percentage of regulatory
Th lymphocytes in older compared to younger SAMP8 mice (Figure 5C). In contrast, SEB administration
increased the percentage of regulatory Th lymphocytes in all groups (p = 0.002). The ratio of activated
to regulatory Th lymphocytes was lower in aged mice, suggesting a reduced immune response to
SEB (p = 0.012, Figure 5D). SDP supplementation did not modify the ratio of activated to regulatory
Th lymphocytes observed in 6-month-old mice. Moreover, there was an interaction between age and
SEB immune response (p = 0.001), since SEB increased this ratio in young mice, while in senescent
mice the ratio was reduced.
Figure 5. Cont.
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Figure 5. Cell recruitment (A); percentage of activated (Act.) Th lymphocytes (B); percentage of
regulatory (Treg) Th lymphocytes (C); and the ratio of activated to regulatory Th lymphocytes (D),
in mesenteric lymph nodes (MLN) of SAMP8 mice of the 2-month-old (2M), 6-month-old (6M),
and 6-month-old fed spray-dried plasma (6M-SDP). The dark grey bars represent groups that received
the vehicle and the light grey bars represent mice administered with S. aureus enterotoxin B (SEB).
Results are expressed as means ± SEM (n = 5–8 animals). Means without a common letter differ,
p < 0.05. Int., interaction between factors (SEB administration and experimental groups; 2M, 6M,
and 6M-SDP).
3.2.3. Effect of SDP on PP Populations in Senescent Mice
SEB administration increased leukocyte recruitment into PP in all of the experimental groups
(p < 0.001; Figure 6A). The percentage of activated Th lymphocytes in PP was higher in senescent
animals than in young animals (p = 0.015; Figure 6B). SDP supplementation did not affect this variable.
Though no clear effects of SEB were observed, there was an interaction between SEB administration
and SDP supplementation (p = 0.001). Senescence was characterized by an increase in the percentage
of regulatory Th lymphocytes in PP (p < 0.001; Figure 6C). SDP supplementation did not attenuate
the effects of senescence on the percentage of regulatory Th lymphocytes in PP, and SEB administration
did not modify this population. The administration of the enterotoxin generated different responses
in the ratio between activated and regulatory Th cells in PP in all of the groups (SEB effect p = 0.008,
Figure 6D). SEB administration increased this ratio in young (2-month-old) and aged (6-month-old)
mice fed the control diet. Moreover, the enterotoxin reduced the activation to regulatory lymphocyte
ratio in the group that received the SDP supplementation. There was an interaction between SEB
administration and SDP supplementation (p < 0.001).
Figure 6. Cont.
Nutrients 2017, 9, 1346 9 of 14
Figure 6. Cell recruitment (A); percentage of activated (Act.) Th lymphocytes (B); percentage of
regulatory (Treg) Th lymphocytes (C); and the ratio of activated to regulatory Th lymphocytes (D),
in Peyer’s patches (PP) of SAMP8 mice of the 2-month-old (2M), 6-month-old (6M), and 6-month-old
fed spray-dried plasma (6M-SDP). The dark grey bars represent groups that received the vehicle and
the light grey bars represent mice administered with S. aureus enterotoxin B (SEB). Results are expressed
as means ± SEM (n = 6–8 animals). Means without a common letter differ, p < 0.05. Int., interaction
between factors (SEB administration and experimental groups; 2M, 6M, and 6M-SDP).
3.2.4. Effect of SDP on Cytokine Expression in Senescent Mice
Senescence increased the expression of Il-6, Tnf-α, and Ifn-γ in the mucosa of the jejunum (p = 0.002,
p = 0.019, and p = 0.006, respectively, Figure 7A–C). This effect was prevented by SDP supplementation
(p = 0.040 for Il-6; p = 0.020 for Tnf-α; and p = 0.026 for Ifn-γ). Moreover, SEB administration
increased the expression of the three cytokines (p = 0.020 for Il-6, p < 0.001 for Tnf-α; and p = 0.009 for
Ifn-γ). Administration of the toxin increased the expression of the anti-inflammatory cytokine Il-10 in
the jejunum mucosa (p < 0.001; Figure 7D). However, senescence impaired the mucosal expression of
this cytokine during the acute inflammation induced by the SEB challenge (p = 0.021).
Figure 7. Cont.
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Figure 7. mRNA expression of Il-6 (A), Tnf-α (B), Ifn-γ (C), and Il-10 (D) in the jejunum mucosa of SAMP8
mice of the 2-month-old (2M), 6-month-old (6M), and 6-month-old fed spray-dried plasma (6M-SDP).
The dark grey bars represent groups that received the vehicle and the light grey bars represent mice
administered with S. aureus enterotoxin B (SEB). All the target genes were normalized to glucuronidase β
(Gusβ) expression. The fold change expression is related to 2M mice administered with vehicle. Results
are expressed as means ± SEM (n = 5–6 animals). Means without a common letter differ, p < 0.05. Int.,
interaction between factors (SEB administration and experimental groups; 2M, 6M, and 6M-SDP).
4. Discussion
Senescence is characterized by an increase in the basal inflammatory state, which contributes
to the development and progression of various diseases associated with aging. This increase
in the inflammatory state leads to a decrease in the functionality of the immune system and
a reduced capacity to respond to the presence of infections or external aggressions, known as
immunosenescence [16]. In addition, this decrease is characterized by low-intensity inflammation
sustained over time, known as inflammaging, with increased production of pro-inflammatory cytokines
and other mediators of inflammation [2,17]. In aged individuals, the gastrointestinal tract is particularly
susceptible to infectious diseases, and this is associated with a lower capacity to respond of the mucosal
immune system [18]. Therefore, more in-depth knowledge of the alterations that occur during the aging
of the immune system would allow us to design strategies to delay immunosenescence and decrease
the incidence of associated pathologies.
We used SAMP8 mice, which are widely used in aging studies, because this strain exhibits
morphological and functional alterations associated with senescence, already at early stages of
development [19]. SAMP8 mice show normal growth and development for the first 2 months of
life, after which they show changes in the immune system associated with aging, such as deterioration
in the capacity of Th lymphocytes to respond [20]. Our results showed that young SAMR1 and SAMP8
mice have similar immune characteristics, although SAMP8 mice have lower lymphocyte counts in
both MLN and PP than SAMR1 mice, and these differences become larger with age.
Aging alters the production of cytokines, which in turn modulates the immune system as
cytokines regulate the growth and differentiation of leukocytes and exhibit numerous biological
activities [21]. Several studies have shown that aging is accompanied by an increase in the production
of pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF-α, which promote chronic inflammation
in the elderly [15,22] and favor the onset and progression of degenerative diseases that are common in
this period [4]. At the same time, increased pro-inflammatory cytokine concentrations in the intestinal
mucosa compromise the integrity and permeability of the epithelium [23]. We observed that aged
mice secrete increased amounts of the pro-inflammatory cytokines Il-6 and Tnf-α from the jejunum
mucosa and that this effect is more pronounced in SAMP8 mice than in the SAMR1 mice. This effect is
accompanied by an increase in the percentage of activated Th lymphocytes from the gut-associated
immune system that is already visible in 6-month-old animals.
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One of the most remarkable alterations that is observed in aging is a decline in the performance
of adaptive immunity mechanisms and the establishment of a mild chronic inflammatory state.
With this in mind, chronic antigenic load and inflammaging are the major causes of aging and
its related diseases [24]. Our current data show that 6-month-old SAMP8 mice already present
an immunosenescence profile as well as inflammaging characteristics typical of old animals, and that
these processes have already begun at 2 months of age. Based on these results, the intestinal immune
response of SAMP8 mice to SEB and the effect of dietary supplementation with SDP were studied.
Elderly people have a decreased capacity to generate adequate adaptive responses, making them
more susceptible to systemic infections and side effects of medication [25]. Aging is characterized
by a loss of the responsiveness of T cells [16] and altered function of Treg lymphocytes which
makes them less efficient at inhibiting the pro-inflammatory activities of other cell types [26,27].
Thus, Treg lymphocytes from aged individuals are less efficient at preventing inflammaging, although
their numbers increase with age in lymphoid tissues. Several studies in mice have demonstrated
a greater presence of Treg lymphocytes in the lymphoid organs of old animals than those of young
animals, while the number in circulating blood remains unchanged [26,28]. Our results demonstrate
that this phenomenon also occurs in the MLN of SAMP8 and SAMR1 mice.
Under basal conditions, we observed that dietary supplementation of 6-month-old SAMP8
mice with SDP prevents the progression of intestinal inflammation, by reducing the expression of
the pro-inflammatory cytokines Il-6, Tnf-α, and Ifn-γ. Moreover, aged mice also had increased serum
concentration of TNF-α and IL-6, thus confirming observations made by Brüünsgaard and Pedersen [5].
The increased plasma concentration of pro-inflammatory cytokines supports the view that aging is
characterized by an inflammatory profile [2]. Dietary SDP supplementation reduced the serum
concentration of pro-inflammatory cytokines, which indicates that SDP reduce the inflammaging
profile observed in aged mice.
Activation of the immune system with superantigens such as SEB leads to increased production of
the pro-inflammatory cytokines TNF-α, IFN-γ, and IL-2 [29]. Our results also showed that 6-month-old
SAMP8 mice have low responsiveness to SEB because no increase in Il-6 or Ifn-γ cytokine expression
was observed. In contrast, the intestinal mucosa of 2-month-old mice, as well as mice fed SDP, showed
an increased production of pro-inflammatory cytokines after SEB administration, as well as an increase
in the anti-inflammatory cytokine Il-10. Our results also indicate that aged SAMP8 mice have
an impaired immune response to SEB, since the number of lymphocytes in GALT remains unchanged
after its administration and the activated Th lymphocyte subpopulation was not increased. In young
SAMP8 mice, however, there was an increase in the recruitment and activation of Th lymphocytes,
in both MLN and PP, indicating that the immune system responds to the toxin. The mice supplemented
with SDP increased the recruitment of lymphocytes in both MLN and PP, as well as the percentage of
activated Th cells in MLN, in response to the enterotoxin in aged mice.
Therefore, although inflammaging results in a large number of alterations at advanced ages,
such as cardiovascular disease or chronic obstructive pulmonary disease [1,2,30], and contributes
to an insufficient response to infections, it does not result in an increased immune response [31,32].
Rather, the data suggest a failure to generate a specific immune response, as well as a subsequent
inability to resolve the inflammation. Our current results indicate that dietary supplementation with
SDP minimizes the loss of the capacity to respond to an infection that occurs in the intestine of senescent
mice; SDP decreases inflammaging and allows a proper response to an inflammatory stimulus.
Changes in the composition of the gut microbiota throughout aging likely contribute to
immunosenescence and to the development of a pro-inflammatory phenotype [33]. There is consistent
evidence supporting the view that SDP supplements can modify the intestinal microbiota. For example,
Torrallardona et al. [34] reported that porcine SDP favors the growth of lactobacilli in the ileum and
cecum of pigs. In rodents, we observed that SDP can increase the frequency of detection of several
species of Lactobacillus in the rat cecum [35] as well as in fecal samples from SAM mice [36]. Preliminary
studies performed in young mice showed that SDP supplementation favors the growth of bacterial
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families that are butyrate and acetate producers [37]. These results suggest that some components in
SDP may be effective in changing the profile of the microbiota, with potential implications for reducing
intestinal and peripheral inflammation.
The effects of dietary supplementation with SDP on GALT have previously been studied in young
animals, but there were no studies of its effects on old animals. Pérez-Bosque et al. [11] found that
SDP has a considerable anti-inflammatory effect after an SEB challenge in young mice, thus averting
an exaggerated reaction by the immune system to the toxin. Several studies of the mechanism
by which dietary SDP modulates the GALT immune system suggest that it decreases mucosal
pro-inflammatory cytokine expression, reduces the activation of Th lymphocytes, and promotes
an abundance of regulatory Th lymphocytes. In addition, dietary SDP also increases the production
of anti-inflammatory cytokines such as IL-10 or TGF-β, which counteract the effects of TNF-α and
other mediators of inflammation. These changes in the cytokine profile may explain the reduced
effects of SEB administration on young mice [11]. In this study, we observed that 6-month-old
SAMP8 mice that received dietary SDP supplementation presented changes in their cytokine profile.
The pro-inflammatory cytokines Il-6, Tnf-α, and Ifn-γ were diminished compared to the aged group,
which would explain the prevention of inflammaging. In addition, SDP decreases the subpopulation
of activated Th lymphocytes in MLN. This decrease in basal inflammation in aged mice is key in
generating a response of the immune system to other stimuli, such as SEB administration. In this way,
the mice that received the SDP feed can respond in a similar way to the younger mice.
5. Conclusions
Senescent mice have an impaired mucosal immune response characterized by unspecific GALT
activation and a weak specific immune response. SDP exerts a modulatory effect on the intestinal
immune system because it decreases basal inflammation associated with age (inflammaging) by
promoting mucosal Treg lymphocytes and IL-10 production. This allows an effective immune response
when mice are challenged with SEB.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/12/1346/s1,
Figure S1: Body weight evolution (A) and food consumption (B) of SAMP8. The body weight of SAMP8 mice was
measured once a month. Food intake was measured three times per week during the feeding period. Results are
expressed as means ± SEM (n = 6–8 mice).
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